It claims that Metseras and its Directors actions, as well as those of Novo Nordisk, are in clear violation of their respective contractual and legal obligations. The second suit: anticompetitive action On Monday, Pfizer filed a second lawsuit against Novo and Metsera claiming Novos bid to acquire Metsera constitutes an anticompetitive action, according to a press release
This daily, cooling eye gel with 70% snail mucin visibly hydrates, brightens, and smooths fine lines
To obecnie jedne z najbardziej przekonujcych dowodw na to, e leczenie oparte na agonistach GLP-1 moe realnie poprawia funkcjonowanie i rokowanie pacjentw z HFpEF
Light energy is absorbed by pigment and blood vessels, breaking them down naturally over time
Secondly, the disproportionality analyses identify statistical associations, which may be confounded by unmeasured factors such as doses, treatment duration, concurrent medications, underlying comorbidities or lifestyle factors